{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:04:48Z","timestamp":1789430688303,"version":"build-2803163510"},"posted":{"date-parts":[[2026,4,24]]},"group-title":"In Review","reference-count":82,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,11]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Background\n Prostate cancer (PCa) exhibits significant ancestry-related disparity. While men of African ancestry experience higher overall mortality rates, this difference is most pronounced in Sub-Saharan Africa and for grade group 1 (GG1) disease, alluding to ancestry-specific biology. Despite this health disparity, African-relevant and prostate tumour GG1 inclusive data, specifically transcriptomic data, is lacking. In turn, this raises significant concerns with regards to adopting Eurocentric models to classify and manage assumed indolent disease for African men. The risk - suboptimal treatment decisions.\nMethods\n Using a single technical and analytical pipeline, we generated total RNA sequencing data from fresh-frozen prostate tissue for 68 Black South African (40 GG1-PCa, 28 non-PCa) and 48 Australian European men (all GG1-PCa), performing ancestry-specific differential gene expression and pathway analysis. Sourcing public data enabled limited African American inclusive The Cancer Genome Atlas cross-validation (13 of 61 GG1-PCa), while Pan Prostate Cancer Group European ancestral data provided for deeper cross-ancestral comparative analyses (106 GG1-PCa, 17 non-PCa).\nResults\n Identifying 5,652 differentially expressed genes between African and European ancestral GG1 tumours (\n                  <italic>p<\/italic>\n                  \u2009&lt;\u20090.05), including top-ranked PCa tumour suppressor genes\n                  <italic>DUSP1, JUN, FOS<\/italic>\n                  , and\n                  <italic>JUNB<\/italic>\n                  downregulated in African tumours. In turn, six metabolic and six immune-related pathways showed significant African-specific negative enrichment. Concordantly, cell type analysis showed significantly lower immune, stromal, and angiogenesis scores in African over European-derived GG1 tumours. Inclusion of African American GG1 data showed pathway over gene-level ancestry-specific concordance, with significant negative enrichment verification for oxidative phosphorylation, fatty acid metabolism and glycolysis. Compared to and irrespective of PCa status, our African tissues showed a 4.9-fold increase in differential gene expression in PSA-high versus PSA-low tissues. Notably, cell type clustering revealed 29% of PSA-high non-PCa tissues exhibited cancer-like profiles, indicating potential occult disease.\nConclusions\n Revealing substantial transcriptomic divergence from European ancestral GG1 tumours, we identify African-specific transcriptomic features that may contribute to outcome disparities in this under-appreciated clinical group. Our study highlights not only a critical shortcoming in providing equitable PCa care for African men, but it also raises major concerns with regards to managing and treating African men using European-developed criteria.\n                <\/p>","DOI":"10.21203\/rs.3.rs-9384143\/v1","type":"posted-content","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:10:01Z","timestamp":1777014601000},"source":"Crossref","is-referenced-by-count":0,"title":["A unique transcriptomic landscape defines African-specific grade group 1 prostate cancer"],"prefix":"10.21203","author":[{"given":"Eva Ferlev","family":"Jensby","sequence":"first","affiliation":[{"name":"Aarhus University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korawich","family":"Uthayopas","sequence":"additional","affiliation":[{"name":"The University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Mehedi","family":"Hasan","sequence":"additional","affiliation":[{"name":"The University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Louw","sequence":"additional","affiliation":[{"name":"National Health Laboratory Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingai B.A.","family":"Mutambirwa","sequence":"additional","affiliation":[{"name":"Sefako Makgatho Health Sciences University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Stricker","sequence":"additional","affiliation":[{"name":"St Vincent's Hospital Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Campbell","sequence":"additional","affiliation":[{"name":"Steve Biko Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lamy","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Marchionni","sequence":"additional","affiliation":[{"name":"NewYork\u2013Presbyterian Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S. Riana","family":"Bornman","sequence":"additional","affiliation":[{"name":"University of Pretoria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Papenfuss","sequence":"additional","affiliation":[{"name":"Walter and Eliza Hall Institute of Medical Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina D.","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"Hayes","sequence":"additional","affiliation":[{"name":"The University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"3","key":"ref1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin May-Jun. 2024;74(3):229\u201363. 10.3322\/caac.21834.","journal-title":"CA Cancer J Clin May-Jun"},{"issue":"1","key":"ref2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12939-023-01962-y","article-title":"Addressing cancer care inequities in sub-Saharan Africa: current challenges and proposed solutions","volume":"11","author":"Omotoso O","year":"2023","unstructured":"Omotoso O, Teibo JO, Atiba FA, Oladimeji T, Paimo OK, Ataya FS, et al. Addressing cancer care inequities in sub-Saharan Africa: current challenges and proposed solutions. Int J Equity Health Sep. 2023;11(1):189. 10.1186\/s12939-023-01962-y.","journal-title":"Int J Equity Health Sep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000530","author":"Epstein JI","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA et al. Feb. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 2016;40(2):244\u2009\u2013\u200952. 10.1097\/PAS.0000000000000530"},{"issue":"23","key":"ref4","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1001\/jama.2018.11716","article-title":"Prostate Cancer-Specific Mortality Across Gleason Scores in Black vs Nonblack Men","volume":"18","author":"Mahal BA","year":"2018","unstructured":"Mahal BA, Berman RA, Taplin ME, Huang FW. Prostate Cancer-Specific Mortality Across Gleason Scores in Black vs Nonblack Men. JAMA Dec. 2018;18(23):2479\u201381. 10.1001\/jama.2018.11716.","journal-title":"JAMA Dec"},{"issue":"5","key":"ref5","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41585-023-00828-w","article-title":"Genetic and biological drivers of prostate cancer disparities in Black men","volume":"21","author":"Gong J","year":"2024","unstructured":"Gong J, Kim DM, Freeman MR, Kim H, Ellis L, Smith B, et al. Genetic and biological drivers of prostate cancer disparities in Black men. Nat Rev Urol May. 2024;21(5):274\u201389. 10.1038\/s41585-023-00828-w.","journal-title":"Nat Rev Urol May"},{"issue":"8","key":"ref6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/pros.22806","article-title":"Clinical presentation of prostate cancer in black South Africans","volume":"74","author":"Tindall EA","year":"2014","unstructured":"Tindall EA, Monare LR, Petersen DC, van Zyl S, Hardie RA, Segone AM, et al. Clinical presentation of prostate cancer in black South Africans. Prostate Jun. 2014;74(8):880\u201391. 10.1002\/pros.22806.","journal-title":"Prostate Jun"},{"issue":"10","key":"ref7","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Schaeffer EM","year":"2023","unstructured":"Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al. Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw Oct. 2023;21(10):1067\u201396. 10.6004\/jnccn.2023.0050.","journal-title":"J Natl Compr Canc Netw Oct"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf117","article-title":"Prostate cancer clinicopathological presentation in South-East Africa during the 2010 decade","volume":"9","author":"Patrick SM","year":"2025","unstructured":"Patrick SM, Ombuki WM, Ndambuki J, Oyaro MO, Bida M, Soh PXY, et al. Prostate cancer clinicopathological presentation in South-East Africa during the 2010 decade. J Natl Cancer Inst May. 2025;9. 10.1093\/jnci\/djaf117.","journal-title":"J Natl Cancer Inst May"},{"issue":"1","key":"ref9","doi-asserted-by":"publisher","first-page":"12013","DOI":"10.1038\/s41598-025-92539-y","article-title":"Associating serum testosterone levels with African ancestral prostate cancer health disparities","volume":"8","author":"Lebelo MT","year":"2025","unstructured":"Lebelo MT, Mmekwa N, Louw M, Jaratlerdsiri W, Mutambirwa SBA, Loda M, et al. Associating serum testosterone levels with African ancestral prostate cancer health disparities. Sci Rep Apr. 2025;8(1):12013. 10.1038\/s41598-025-92539-y.","journal-title":"Sci Rep Apr"},{"issue":"7927","key":"ref10","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41586-022-05154-6","article-title":"African-specific molecular taxonomy of prostate cancer","volume":"609","author":"Jaratlerdsiri W","year":"2022","unstructured":"Jaratlerdsiri W, Jiang J, Gong T, Patrick SM, Willet C, Chew T, et al. African-specific molecular taxonomy of prostate cancer. Nature Sep. 2022;609(7927):552\u20139. 10.1038\/s41586-022-05154-6.","journal-title":"Nature Sep"},{"issue":"10","key":"ref11","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/pros.23823","article-title":"TMPRSS2-ERG fusions linked to prostate cancer racial health disparities: A focus on Africa","volume":"79","author":"Blackburn J","year":"2019","unstructured":"Blackburn J, Vecchiarelli S, Heyer EE, Patrick SM, Lyons RJ, Jaratlerdsiri W, et al. TMPRSS2-ERG fusions linked to prostate cancer racial health disparities: A focus on Africa. Prostate Jul. 2019;79(10):1191\u20136. 10.1002\/pros.23823.","journal-title":"Prostate Jul"},{"issue":"1","key":"ref12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s40615-023-01534-4","article-title":"Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer","volume":"11","author":"Lee KY","year":"2024","unstructured":"Lee KY, Beatson EL, Steinberg SM, Chau CH, Price DK, Figg WD. Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer. J Racial Ethn Health Disparities Feb. 2024;11(1):492\u2013504. 10.1007\/s40615-023-01534-4.","journal-title":"J Racial Ethn Health Disparities Feb"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"911101","DOI":"10.3389\/fgene.2022.911101","article-title":"Review of prostate cancer genomic studies in Africa","volume":"13","author":"Samtal C","year":"2022","unstructured":"Samtal C, El Jaddaoui I, Hamdi S, Bouguenouch L, Ouldim K, Nejjari C, et al. Review of prostate cancer genomic studies in Africa. Front Genet. 2022;13:911101. 10.3389\/fgene.2022.911101.","journal-title":"Front Genet"},{"issue":"4","key":"ref14","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The Molecular Taxonomy of Primary Prostate Cancer","volume":"5","author":"Cancer Genome Atlas Research N","year":"2015","unstructured":"Cancer Genome Atlas Research N. The Molecular Taxonomy of Primary Prostate Cancer. Cell Nov. 2015;5(4):1011\u201325. 10.1016\/j.cell.2015.10.025.","journal-title":"Cell Nov"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"810159","DOI":"10.1155\/2015\/810159","article-title":"Atypical Small Acinar Proliferation: Repeat Biopsy and Detection of High Grade Prostate Cancer","volume":"2015","author":"Leone A","year":"2015","unstructured":"Leone A, Rotker K, Butler C, Mega A, Li J, Amin A, et al. Atypical Small Acinar Proliferation: Repeat Biopsy and Detection of High Grade Prostate Cancer. Prostate Cancer. 2015;2015:810159. 10.1155\/2015\/810159.","journal-title":"Prostate Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","author":"Ahmed HU","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017. 10.1016\/S0140-6736(16)32401-1.","journal-title":"Lancet"},{"issue":"4","key":"ref17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/(sici)1097-0045(19981201)37:4<230::aid-pros4>3.0.co;2-l","article-title":"Racial differences and prognostic significance of tumor location in radical prostatectomy specimens","volume":"1","author":"Tiguert R","year":"1998","unstructured":"Tiguert R, Gheiler EL, Tefilli MV, Banerjee M, Grignon DJ, Sakr W, et al. Racial differences and prognostic significance of tumor location in radical prostatectomy specimens. Prostate Dec. 1998;1(4):230\u20135. 10.1002\/(sici)1097-0045(19981201)37:4%3C230::aid-pros4%3E3.0.co;2-l.","journal-title":"Prostate Dec"},{"issue":"12","key":"ref18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love MI","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. 10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"ref19","volume-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","unstructured":"Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal."},{"issue":"4","key":"ref20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro R","year":"2017","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods Apr. 2017;14(4):417\u20139. 10.1038\/nmeth.4197.","journal-title":"Nat Methods Apr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.2","article-title":"Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences","volume":"4","author":"Soneson C","year":"2015","unstructured":"Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res. 2015;4:1521. 10.12688\/f1000research.7563.2.","journal-title":"F1000Res"},{"issue":"1","key":"ref22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41587-022-01440-w","article-title":"Removing unwanted variation from large-scale RNA sequencing data with PRPS","volume":"41","author":"Molania R","year":"2023","unstructured":"Molania R, Foroutan M, Gagnon-Bartsch JA, Gandolfo LC, Jain A, Sinha A, et al. Removing unwanted variation from large-scale RNA sequencing data with PRPS. Nat Biotechnol Jan. 2023;41(1):82\u201395. 10.1038\/s41587-022-01440-w.","journal-title":"Nat Biotechnol Jan"},{"key":"ref23","unstructured":"FastQC: A quality control tool for high throughput sequence data. 2010. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1101\/060012","article-title":"Fast gene set enrichment analysis","author":"Korotkevich G","year":"2019","unstructured":"Korotkevich G, Sukhov V, Sergushichev A. Fast gene set enrichment analysis. bioRxiv. 2019. 10.1101\/060012.","journal-title":"bioRxiv"},{"issue":"11","key":"ref25","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data","volume":"19","author":"Xu S","year":"2024","unstructured":"Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, et al. Using clusterProfiler to characterize multiomics data. Nat Protoc Nov. 2024;19(11):3292\u2013320. 10.1038\/s41596-024-01020-z.","journal-title":"Nat Protoc Nov"},{"issue":"6","key":"ref26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"23","author":"Liberzon A","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst Dec. 2015;23(6):417\u201325. 10.1016\/j.cels.2015.12.004.","journal-title":"Cell Syst Dec"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"16","author":"Hanzelmann S","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics Jan. 2013;16:14:7. 10.1186\/1471-2105-14-7.","journal-title":"BMC Bioinformatics Jan"},{"issue":"3","key":"ref28","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu Z","year":"2022","unstructured":"Gu Z. Complex heatmap visualization. Imeta Sep. 2022;1(3):e43. 10.1002\/imt2.43.","journal-title":"Imeta Sep"},{"issue":"12","key":"ref29","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1016\/j.celrep.2018.11.086","article-title":"A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra","volume":"18","author":"Henry GH","year":"2018","unstructured":"Henry GH, Malewska A, Joseph DB, Malladi VS, Lee J, Torrealba J, et al. A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra. Cell Rep Dec. 2018;18(12):3530\u2013e35425. 10.1016\/j.celrep.2018.11.086.","journal-title":"Cell Rep Dec"},{"issue":"11","key":"ref30","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1080\/15384101.2023.2206502","article-title":"Basal epithelial cells in prostate development, tumorigenesis, and cancer progression","volume":"22","author":"Pitzen SP","year":"2023","unstructured":"Pitzen SP, Dehm SM. Basal epithelial cells in prostate development, tumorigenesis, and cancer progression. Cell Cycle Jun. 2023;22(11):1303\u201318. 10.1080\/15384101.2023.2206502.","journal-title":"Cell Cycle Jun"},{"issue":"14","key":"ref31","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1002\/cncr.34790","article-title":"A novel prostate cancer subtyping classifier based on luminal and basal phenotypes","volume":"15","author":"Weiner AB","year":"2023","unstructured":"Weiner AB, Liu Y, Hakansson A, Zhao X, Proudfoot JA, Ho J, et al. A novel prostate cancer subtyping classifier based on luminal and basal phenotypes. Cancer Jul. 2023;15(14):2169\u201378. 10.1002\/cncr.34790.","journal-title":"Cancer Jul"},{"issue":"21","key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16213685","article-title":"Deciphering the Tumor Microenvironment in Prostate Cancer: A Focus on the Stromal Component","volume":"31","author":"Pakula H","year":"2024","unstructured":"Pakula H, Pederzoli F, Fanelli GN, Nuzzo PV, Rodrigues S, Loda M. Deciphering the Tumor Microenvironment in Prostate Cancer: A Focus on the Stromal Component. Cancers (Basel) Oct. 2024;31(21). 10.3390\/cancers16213685.","journal-title":"Cancers (Basel) Oct"},{"issue":"12","key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124449","article-title":"Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis","volume":"23","author":"Adekoya TO","year":"2020","unstructured":"Adekoya TO, Richardson RM. Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis. Int J Mol Sci Jun. 2020;23(12). 10.3390\/ijms21124449.","journal-title":"Int J Mol Sci Jun"},{"issue":"6","key":"ref34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1159\/000541881","article-title":"The Immune Microenvironment in Prostate Cancer: A Comprehensive Review","volume":"103","author":"Novysedlak R","year":"2025","unstructured":"Novysedlak R, Guney M, Al Khouri M, Bartolini R, Koumbas Foley L, Benesova I, et al. The Immune Microenvironment in Prostate Cancer: A Comprehensive Review. Oncology. 2025;103(6):521\u201345. 10.1159\/000541881.","journal-title":"Oncology"},{"issue":"9","key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092382","article-title":"Angiogenesis Inhibition in Prostate Cancer: An Update","volume":"23","author":"Sarkar C","year":"2020","unstructured":"Sarkar C, Goswami S, Basu S, Chakroborty D. Angiogenesis Inhibition in Prostate Cancer: An Update. Cancers (Basel) Aug. 2020;23(9). 10.3390\/cancers12092382.","journal-title":"Cancers (Basel) Aug"},{"issue":"3","key":"ref36","first-page":"671","article-title":"Involvement of endothelial PECAM-1\/CD31 in angiogenesis","volume":"151","author":"DeLisser HM","year":"1997","unstructured":"DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, et al. Involvement of endothelial PECAM-1\/CD31 in angiogenesis. Am J Pathol Sep. 1997;151(3):671\u20137.","journal-title":"Am J Pathol Sep"},{"issue":"2","key":"ref37","doi-asserted-by":"publisher","first-page":"e0228590","DOI":"10.1371\/journal.pone.0228590","article-title":"Genome-wide analysis of HOXC4 and HOXC6 regulated genes and binding sites in prostate cancer cells","volume":"15","author":"Luo Z","year":"2020","unstructured":"Luo Z, Farnham PJ. Genome-wide analysis of HOXC4 and HOXC6 regulated genes and binding sites in prostate cancer cells. PLoS ONE. 2020;15(2):e0228590. 10.1371\/journal.pone.0228590.","journal-title":"PLoS ONE"},{"issue":"13","key":"ref38","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1001\/jama.287.13.1662","article-title":"alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer","volume":"3","author":"Rubin MA","year":"2002","unstructured":"Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, et al. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA Apr. 2002;3(13):1662\u201370. 10.1001\/jama.287.13.1662.","journal-title":"JAMA Apr"},{"issue":"23","key":"ref39","first-page":"5975","article-title":"DD3: a new prostate-specific gene, highly overexpressed in prostate cancer","volume":"1","author":"Bussemakers MJ","year":"1999","unstructured":"Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res Dec. 1999;1(23):5975\u20139.","journal-title":"Cancer Res Dec"},{"issue":"1","key":"ref40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/1078-1439(95)00002-y","article-title":"Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues","volume":"1","author":"Wright GL","year":"1995","unstructured":"Wright GL Jr., Haley C, Beckett ML, Schellhammer PF. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. Urol Oncol Jan-Feb. 1995;1(1):18\u201328. 10.1016\/1078-1439(95)00002-y.","journal-title":"Urol Oncol Jan-Feb"},{"issue":"5","key":"ref41","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/ijc.21270","article-title":"Dual-specificity phosphatase 1 and serum\/glucocorticoid-regulated kinase are downregulated in prostate cancer","volume":"10","author":"Rauhala HE","year":"2005","unstructured":"Rauhala HE, Porkka KP, Tolonen TT, Martikainen PM, Tammela TL, Visakorpi T. Dual-specificity phosphatase 1 and serum\/glucocorticoid-regulated kinase are downregulated in prostate cancer. Int J Cancer Dec. 2005;10(5):738\u201345. 10.1002\/ijc.21270.","journal-title":"Int J Cancer Dec"},{"issue":"1","key":"ref42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12943-024-02022-x","article-title":"JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression","volume":"29","author":"Redmer T","year":"2024","unstructured":"Redmer T, Raigel M, Sternberg C, Ziegler R, Probst C, Lindner D, et al. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression. Mol Cancer May. 2024;29(1):114. 10.1186\/s12943-024-02022-x.","journal-title":"Mol Cancer May"},{"issue":"13","key":"ref43","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1038\/s41388-021-01724-6","article-title":"In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun","volume":"40","author":"Riedel M","year":"2021","unstructured":"Riedel M, Berthelsen MF, Cai H, Haldrup J, Borre M, Paludan SR, et al. In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun. Oncogene Apr. 2021;40(13):2437\u201347. 10.1038\/s41388-021-01724-6.","journal-title":"Oncogene Apr"},{"issue":"4","key":"ref44","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/cdd.2014.213","article-title":"Loss of JUNB\/AP-1 promotes invasive prostate cancer","volume":"22","author":"Thomsen MK","year":"2015","unstructured":"Thomsen MK, Bakiri L, Hasenfuss SC, Wu H, Morente M, Wagner EF. Loss of JUNB\/AP-1 promotes invasive prostate cancer. Cell Death Differ Apr. 2015;22(4):574\u201382. 10.1038\/cdd.2014.213.","journal-title":"Cell Death Differ Apr"},{"issue":"11","key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/cells14110761","article-title":"CYR61 as a Potential Biomarker and Target in Cancer Prognosis and Therapies","volume":"22","author":"Schenker AJ","year":"2025","unstructured":"Schenker AJ, Ortiz-Hernandez GL. CYR61 as a Potential Biomarker and Target in Cancer Prognosis and Therapies. Cells May. 2025;22(11). 10.3390\/cells14110761.","journal-title":"Cells May"},{"issue":"3","key":"ref46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/aja.2011.149","article-title":"Cyr61 is a potential prognostic marker for prostate cancer","volume":"14","author":"Terada N","year":"2012","unstructured":"Terada N, Kulkarni P, Getzenberg RH. Cyr61 is a potential prognostic marker for prostate cancer. Asian J Androl May. 2012;14(3):405\u20138. 10.1038\/aja.2011.149.","journal-title":"Asian J Androl May"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/bcb-2024-0155","article-title":"The potential role of AhR\/NR4A1 in androgen-dependent prostate cancer: focus on TCDD-induced ferroptosis","volume":"1","author":"Chen X","year":"2025","unstructured":"Chen X, Yao Y, Gong G, He T, Ma C, Yu J. The potential role of AhR\/NR4A1 in androgen-dependent prostate cancer: focus on TCDD-induced ferroptosis. Biochem Cell Biol Jan. 2025;1:103:1\u201311. 10.1139\/bcb-2024-0155.","journal-title":"Biochem Cell Biol Jan"},{"issue":"1","key":"ref48","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s42003-021-02140-y","article-title":"Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences","volume":"3","author":"Rayford W","year":"2021","unstructured":"Rayford W, Beksac AT, Alger J, Alshalalfa M, Ahmed M, Khan I, et al. Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences. Commun Biol Jun. 2021;3(1):670. 10.1038\/s42003-021-02140-y.","journal-title":"Commun Biol Jun"},{"issue":"1","key":"ref49","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-022-01080-1","article-title":"Hypoxia signaling in human health and diseases: implications and prospects for therapeutics","volume":"7","author":"Luo Z","year":"2022","unstructured":"Luo Z, Tian M, Yang G, Tan Q, Chen Y, Li G, et al. Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. Signal Transduct Target Ther Jul. 2022;7(1):218. 10.1038\/s41392-022-01080-1.","journal-title":"Signal Transduct Target Ther Jul"},{"key":"ref50","article-title":"SREBF2 sterol regulatory element binding transcription factor 2 [ Homo sapiens (human) ]","author":"(NCBI) NCfBI","year":"2025","unstructured":"(NCBI) NCfBI. SREBF2 sterol regulatory element binding transcription factor 2 [ Homo sapiens (human) ]. Accessed 1\/12-2025, 2025. https:\/\/www.ncbi.nlm.nih.gov\/gene\/6721"},{"issue":"5","key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12051075","article-title":"PGC-1alpha Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response","volume":"10","author":"Abu Shelbayeh O","year":"2023","unstructured":"Abu Shelbayeh O, Arroum T, Morris S, Busch KB. PGC-1alpha Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response. Antioxidants (Basel) May. 2023;10(5). 10.3390\/antiox12051075.","journal-title":"Antioxidants (Basel) May"},{"issue":"41","key":"ref52","doi-asserted-by":"publisher","first-page":"14635","DOI":"10.1073\/pnas.0507342102","article-title":"RelA repression of RelB activity induces selective gene activation downstream of TNF receptors","volume":"11","author":"Jacque E","year":"2005","unstructured":"Jacque E, Tchenio T, Piton G, Romeo PH, Baud V. RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. Proc Natl Acad Sci U S A Oct. 2005;11(41):14635\u201340. 10.1073\/pnas.0507342102.","journal-title":"Proc Natl Acad Sci U S A Oct"},{"issue":"1","key":"ref53","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"26","author":"Hu X","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther Nov. 2021;26(1):402. 10.1038\/s41392-021-00791-1.","journal-title":"Signal Transduct Target Ther Nov"},{"issue":"Pt 24","key":"ref54","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1242\/jcs.114.24.4359","article-title":"Smad regulation in TGF-beta signal transduction","volume":"114","author":"Moustakas A","year":"2001","unstructured":"Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGF-beta signal transduction. J Cell Sci Dec. 2001;114(Pt 24):4359\u201369. 10.1242\/jcs.114.24.4359.","journal-title":"J Cell Sci Dec"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115938","author":"Ren Q","year":"2023","unstructured":"Ren Q, Liu Z, Wu L, Yin G, Xie X, Kong W et al. C\/EBPbeta: The structure, regulation, and its roles in inflammation-related diseases. Biomed Pharmacother. Dec 31. 2023;169:115938. 10.1016\/j.biopha.2023.115938"},{"issue":"1","key":"ref56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","article-title":"Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat","volume":"10","author":"Dong Y","year":"2020","unstructured":"Dong Y, Tu R, Liu H, Qing G. Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat. Signal Transduct Target Ther Jul. 2020;10(1):124. 10.1038\/s41392-020-00235-2.","journal-title":"Signal Transduct Target Ther Jul"},{"issue":"6","key":"ref57","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1194\/jlr.M001123","article-title":"PPARdelta is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction","volume":"51","author":"Ravnskjaer K","year":"2010","unstructured":"Ravnskjaer K, Frigerio F, Boergesen M, Nielsen T, Maechler P, Mandrup S. PPARdelta is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction. J Lipid Res Jun. 2010;51(6):1370\u20139. 10.1194\/jlr.M001123.","journal-title":"J Lipid Res Jun"},{"issue":"2","key":"ref58","doi-asserted-by":"publisher","first-page":"382","DOI":"10.7150\/jca.126397","article-title":"Comparative Blood-Based Transcriptomic Profiles of Prostate Cancer Patients from South Africa and the USA: A Cross-Sectional Pilot Study","volume":"17","author":"Koduru SV","year":"2026","unstructured":"Koduru SV, Kidd M, Pieters A, Nagel SE, Millar RP, Halim AB. Comparative Blood-Based Transcriptomic Profiles of Prostate Cancer Patients from South Africa and the USA: A Cross-Sectional Pilot Study. J Cancer. 2026;17(2):382\u201394. 10.7150\/jca.126397.","journal-title":"J Cancer"},{"issue":"1","key":"ref59","doi-asserted-by":"publisher","first-page":"8037","DOI":"10.1038\/s41467-023-43726-w","article-title":"Prostate cancer genetic risk and associated aggressive disease in men of African ancestry","volume":"5","author":"Soh PXY","year":"2023","unstructured":"Soh PXY, Mmekwa N, Petersen DC, Gheybi K, van Zyl S, Jiang J, et al. Prostate cancer genetic risk and associated aggressive disease in men of African ancestry. Nat Commun Dec. 2023;5(1):8037. 10.1038\/s41467-023-43726-w.","journal-title":"Nat Commun Dec"},{"issue":"1","key":"ref60","doi-asserted-by":"publisher","first-page":"8799","DOI":"10.1038\/s41467-025-63865-6","article-title":"Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry","volume":"2","author":"Gheybi K","year":"2025","unstructured":"Gheybi K, Soh PXY, Jiang J, Mbeki TMN, Louw M, Burns D, et al. Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry. Nat Commun Oct. 2025;2(1):8799. 10.1038\/s41467-025-63865-6.","journal-title":"Nat Commun Oct"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"7375879","DOI":"10.1155\/2022\/7375879","article-title":"LMX1B Activated Circular RNA GFRA1 Modulates the Tumorigenic Properties and Immune Escape of Prostate Cancer","volume":"2022","author":"Meng M","year":"2022","unstructured":"Meng M, Wu YC. LMX1B Activated Circular RNA GFRA1 Modulates the Tumorigenic Properties and Immune Escape of Prostate Cancer. J Immunol Res. 2022;2022:7375879. 10.1155\/2022\/7375879.","journal-title":"J Immunol Res"},{"issue":"1","key":"ref62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.yexcr.2018.01.007","article-title":"DLX1, a binding protein of beta-catenin, promoted the growth and migration of prostate cancer cells","volume":"1","author":"Liang M","year":"2018","unstructured":"Liang M, Sun Y, Yang HL, Zhang B, Wen J, Shi BK. DLX1, a binding protein of beta-catenin, promoted the growth and migration of prostate cancer cells. Exp Cell Res Feb. 2018;1(1):26\u201332. 10.1016\/j.yexcr.2018.01.007.","journal-title":"Exp Cell Res Feb"},{"issue":"4","key":"ref63","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ccell.2018.03.006","article-title":"lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer","volume":"9","author":"Wang Z","year":"2018","unstructured":"Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, et al. lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer. Cancer Cell Apr. 2018;9(4):706\u2013e7209. 10.1016\/j.ccell.2018.03.006.","journal-title":"Cancer Cell Apr"},{"issue":"7","key":"ref64","doi-asserted-by":"publisher","first-page":"e22158","DOI":"10.1002\/jbt.22158","article-title":"Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro","volume":"2","author":"Su WP","year":"2018","unstructured":"Su WP, Sun LN, Yang SL, Zhao H, Zeng TY, Wu WZ, et al. Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro. J Biochem Mol Toxicol May. 2018;2(7):e22158. 10.1002\/jbt.22158.","journal-title":"J Biochem Mol Toxicol May"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"113445","DOI":"10.1016\/j.intimp.2024.113445","article-title":"Modulating Treg cell activity in prostate cancer via chitosan nanoparticles loaded with si-BATF\/PRDM1","volume":"10","author":"Zhao Z","year":"2025","unstructured":"Zhao Z, An R, Tang W, Chen J, Xu R, Kan L. Modulating Treg cell activity in prostate cancer via chitosan nanoparticles loaded with si-BATF\/PRDM1. Int Immunopharmacol Jan. 2025;10:144:113445. 10.1016\/j.intimp.2024.113445.","journal-title":"Int Immunopharmacol Jan"},{"issue":"33","key":"ref66","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1038\/onc.2008.91","article-title":"Phosphoinositide 3-OH kinase p85alpha and p110beta are essential for androgen receptor transactivation and tumor progression in prostate cancers","volume":"31","author":"Zhu Q","year":"2008","unstructured":"Zhu Q, Youn H, Tang J, Tawfik O, Dennis K, Terranova PF, et al. Phosphoinositide 3-OH kinase p85alpha and p110beta are essential for androgen receptor transactivation and tumor progression in prostate cancers. Oncogene Jul. 2008;31(33):4569\u201379. 10.1038\/onc.2008.91.","journal-title":"Oncogene Jul"},{"issue":"1","key":"ref67","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s42003-022-03227-w","article-title":"Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1","volume":"1","author":"Makino Y","year":"2022","unstructured":"Makino Y, Kamiyama Y, Brown JB, Tanaka T, Murakami R, Teramoto Y, et al. Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1. Commun Biol Apr. 2022;1(1):299. 10.1038\/s42003-022-03227-w.","journal-title":"Commun Biol Apr"},{"issue":"12","key":"ref68","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/s44320-025-00153-x","article-title":"Methylation reprogramming associated with aggressive prostate cancer and ancestral disparities","volume":"21","author":"Craddock J","year":"2025","unstructured":"Craddock J, Lutsik P, Soh PXY, Louw M, Hasan MM, Patrick SM, et al. Methylation reprogramming associated with aggressive prostate cancer and ancestral disparities. Mol Syst Biol Dec. 2025;21(12):1676\u2013701. 10.1038\/s44320-025-00153-x.","journal-title":"Mol Syst Biol Dec"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"126265","DOI":"10.1016\/j.jhazmat.2021.126265","article-title":"Global status of dioxin emission and China's role in reducing the emission","volume":"15","author":"Lei R","year":"2021","unstructured":"Lei R, Xu Z, Xing Y, Liu W, Wu X, Jia T, et al. Global status of dioxin emission and China's role in reducing the emission. J Hazard Mater Sep. 2021;15:418:126265. 10.1016\/j.jhazmat.2021.126265.","journal-title":"J Hazard Mater Sep"},{"issue":"3","key":"ref70","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00244-024-01088-4","article-title":"PFOS, and 20 other Persistent Organic Pollutants in Eggs of Nine Wild Bird Species from the Vaal River, South Africa","volume":"87","author":"Lesch V","year":"2024","unstructured":"Lesch V, Pieters R, Bouwman H, Dioxins. PFOS, and 20 other Persistent Organic Pollutants in Eggs of Nine Wild Bird Species from the Vaal River, South Africa. Arch Environ Contam Toxicol Oct. 2024;87(3):287\u2013310. 10.1007\/s00244-024-01088-4.","journal-title":"Arch Environ Contam Toxicol Oct"},{"issue":"1","key":"ref71","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1038\/s41467-025-57312-9","article-title":"Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men","volume":"10","author":"Gong T","year":"2025","unstructured":"Gong T, Jiang J, Uthayopas K, Bornman MSR, Gheybi K, Stricker PD, et al. Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men. Nat Commun Mar. 2025;10(1):2400. 10.1038\/s41467-025-57312-9.","journal-title":"Nat Commun Mar"},{"issue":"1","key":"ref72","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","article-title":"Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses","volume":"7","author":"Hirz T","year":"2023","unstructured":"Hirz T, Mei S, Sarkar H, Kfoury Y, Wu S, Verhoeven BM, et al. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Nat Commun Feb. 2023;7(1):663. 10.1038\/s41467-023-36325-2.","journal-title":"Nat Commun Feb"},{"issue":"1","key":"ref73","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/s41467-022-29235-2","article-title":"Serum proteomics links suppression of tumor immunity to ancestry and lethal prostate cancer","volume":"1","author":"Minas TZ","year":"2022","unstructured":"Minas TZ, Candia J, Dorsey TH, Baker F, Tang W, Kiely M, et al. Serum proteomics links suppression of tumor immunity to ancestry and lethal prostate cancer. Nat Commun Apr. 2022;1(1):1759. 10.1038\/s41467-022-29235-2.","journal-title":"Nat Commun Apr"},{"issue":"1","key":"ref74","doi-asserted-by":"publisher","first-page":"e1817","DOI":"10.1002\/cnr2.1817","article-title":"Prostate malignant tumor and benign prostatic hyperplasia microenvironments in black African men: Limited infiltration of CD8\u2009+\u2009T lymphocytes, NK-cells, and high frequency of CD73\u2009+\u2009stromal cells","volume":"6","author":"Mougola Bissiengou P","year":"2023","unstructured":"Mougola Bissiengou P, Montcho Comlan JG, Atsame Ebang G, Sylla Niang M, Djoba Siawaya JF. Prostate malignant tumor and benign prostatic hyperplasia microenvironments in black African men: Limited infiltration of CD8\u2009+\u2009T lymphocytes, NK-cells, and high frequency of CD73\u2009+\u2009stromal cells. Cancer Rep (Hoboken) Sep. 2023;6(1):e1817. 10.1002\/cnr2.1817.","journal-title":"Cancer Rep (Hoboken) Sep"},{"issue":"9","key":"ref75","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41416-021-01435-5","article-title":"Metabolic reprogramming in prostate cancer","volume":"125","author":"Ahmad F","year":"2021","unstructured":"Ahmad F, Cherukuri MK, Choyke PL. Metabolic reprogramming in prostate cancer. Br J Cancer Oct. 2021;125(9):1185\u201396. 10.1038\/s41416-021-01435-5.","journal-title":"Br J Cancer Oct"},{"issue":"1","key":"ref76","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12301-023-00372-4","article-title":"Sensitivity and specificity of prostate-specific antigen and its surrogates towards the detection of prostate cancer in sub-Saharan Africa: a systematic review with meta-analysis","volume":"29","author":"Okwor CJ","year":"2023","unstructured":"Okwor CJ, Nnakenyi ID, Agbo EO, Nweke M. Sensitivity and specificity of prostate-specific antigen and its surrogates towards the detection of prostate cancer in sub-Saharan Africa: a systematic review with meta-analysis. Afr J Urol. 2023;29(1):41. 10.1186\/s12301-023-00372-4. 2023\/08\/05.","journal-title":"Afr J Urol"},{"issue":"1","key":"ref77","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/bju.16178","article-title":"Global viewpoints: updates on prostate cancer in Sub-Saharan Africa","volume":"133","author":"Jalloh M","year":"2024","unstructured":"Jalloh M, Cassell A, Niang L, Rebbeck T. Global viewpoints: updates on prostate cancer in Sub-Saharan Africa. BJU Int Jan. 2024;133(1):6\u201313. 10.1111\/bju.16178.","journal-title":"BJU Int Jan"},{"issue":"R1","key":"ref78","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1093\/hmg\/ddaa274","article-title":"Bantu-speaker migration and admixture in southern Africa","volume":"26","author":"Choudhury A","year":"2021","unstructured":"Choudhury A, Sengupta D, Ramsay M, Schlebusch C. Bantu-speaker migration and admixture in southern Africa. Hum Mol Genet Apr. 2021;26(R1):R56\u201363. 10.1093\/hmg\/ddaa274.","journal-title":"Hum Mol Genet Apr"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-69269-4","article-title":"A catalogue of early diverged contemporary human genome variation reveals distinct Khoe-San populations","volume":"10","author":"Jaratlerdsiri W","year":"2026","unstructured":"Jaratlerdsiri W, Soh PXY, Gong T, Jiang J, Simayi Z, Petersen DC, et al. A catalogue of early diverged contemporary human genome variation reveals distinct Khoe-San populations. Nat Commun Feb. 2026;10. 10.1038\/s41467-026-69269-4.","journal-title":"Nat Commun Feb"},{"issue":"2","key":"ref80","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ajhg.2020.06.012","article-title":"Genetic Consequences of the Transatlantic Slave Trade in the Americas","volume":"6","author":"Micheletti SJ","year":"2020","unstructured":"Micheletti SJ, Bryc K, Ancona Esselmann SG, Freyman WA, Moreno ME, Poznik GD, et al. Genetic Consequences of the Transatlantic Slave Trade in the Americas. Am J Hum Genet Aug. 2020;6(2):265\u201377. 10.1016\/j.ajhg.2020.06.012.","journal-title":"Am J Hum Genet Aug"},{"issue":"2","key":"ref81","doi-asserted-by":"publisher","first-page":"144","DOI":"10.22465\/juo.244800340017","article-title":"Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion","volume":"7","author":"Hayes VM","year":"2024","unstructured":"Hayes VM, Patrick SM, Shirinde J, Jaratlerdsiri W, Nenzhelele M, Radzuma MB, et al. Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion. J Urol Oncol. 2024;7(2):144\u20139. 10.22465\/juo.244800340017.","journal-title":"J Urol Oncol"},{"issue":"20","key":"ref82","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"27","author":"World Medical A","year":"2013","unstructured":"World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA Nov. 2013;27(20):2191\u20134. 10.1001\/jama.2013.281053.","journal-title":"JAMA Nov"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9384143\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9384143\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:54:51Z","timestamp":1789430091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9384143\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":82,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9384143\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,4,24]]},"subtype":"preprint"}}